Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-04-09-Speech-3-373"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20030409.7.3-373"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"Mr President, Commissioner, I hope with all my heart that this report, into which Mr Liese has poured so much energy, will have a natural birth without the need for forceps like the report on blood, which had long been the subject of controversy but for which we succeeded in finding a solution after many years thanks to active, intelligent, enthusiastic cooperation between Parliament, the Commission and the Council. I shall mention just a few points this evening – four, in particular. Firstly, I feel that it is right – as Mr Liese said – that the donation of cells and tissues should be on a voluntary basis and unpaid, a principle already endorsed when the report on blood was adopted. However, where industry has helped to improve the quality and conservation of cells and tissues, for example by using genetic engineering techniques to make tissues histocompatible, it is right to allow for appropriate payment. Secondly, I hope that Amendment No 83, proposed by myself and Mr Liese, will be adopted. It calls upon the Commission to draw up new legislation on the use of retrodifferentiation to create stem cells from adult cells as soon as possible. The retrodifferentiation of adult cells, achieved by transferring their nucleus, rather than to an egg cell without a nucleus, to a medium rich in nutritive elements and other growth factors, could make it possible to overcome the current ethical problems connected with the therapeutic use of stem cells from human embryos. Thirdly, as regards the use of stem cells for research purposes, I hope that the rules laid down in the Sixth Framework Programme will always remain in force and that we do not let anything in by the back door today that should not be there. Fourthly and lastly, I support the Commission’s proposal that the directive should cover the use of cells and tissues for research purposes where this is carried out on human beings but not where experimental research is carried out or on animal models. I would therefore call upon the rapporteur, Mr Liese, should Amendments Nos 7 and 19 be adopted, to introduce more flexibility at second reading to avoid unwieldy administrative procedures slowing down research in Europe in key fields such as pharmacogenetics and pharmacogenomics, for example, whose objective is to develop new drugs which are much more effective and have no toxic action."@en1
lpv:unclassifiedMetadata

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph